Diode laser endophotocoagulation

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: To evaluate the utility, safety, and reliability of diode laser endophotocoagulation in a sizable clinical series. Methods: Two hundred twenty-six consecutive eyes treated with diode endophotocoagulation were studied prospectively. Surgical indications included proliferative diabetic retinopathy (134 eyes), proliferative vitreoretinopathy (27 eyes), complicated retinal detachment (50 eyes), and miscellaneous (15 eyes). A retrospective comparison group of 67 consecutive eyes undergoing vitrectomy with argon endolaser photocoagulation was also studied. Results: The desired intraoperative effect of diode endophotocoagulation was achieved in 99.6% cases without complication. Final visual acuity was improved in 159 eyes (71%), and was 5/200 or better in 157 eyes (70%) with diode endophotocoagulation. In comparison, final visual acuity was improved in 48 eyes (73%), and was 5/200 or better in 45 eyes (68%) for argon endophotocoagulation. No statistically significant difference was found between the two groups regarding rate of visual improvement or final visual results. Conclusion: This series supports the conclusion that the diode laser is as safe, reliable, and effective for endophotocoagulation as argon treatment.

Original languageEnglish
Pages (from-to)388-393
Number of pages6
JournalRetina
Volume15
Issue number5
StatePublished - Nov 13 1995
Externally publishedYes

Fingerprint

Semiconductor Lasers
Argon
Visual Acuity
Proliferative Vitreoretinopathy
Light Coagulation
Vitrectomy
Retinal Detachment
Diabetic Retinopathy
Safety

Keywords

  • diode laser
  • endophotocoagulation
  • vitrectomy

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Sasoh, M., & Smiddy, W. E. (1995). Diode laser endophotocoagulation. Retina, 15(5), 388-393.

Diode laser endophotocoagulation. / Sasoh, M.; Smiddy, William E.

In: Retina, Vol. 15, No. 5, 13.11.1995, p. 388-393.

Research output: Contribution to journalArticle

Sasoh, M & Smiddy, WE 1995, 'Diode laser endophotocoagulation', Retina, vol. 15, no. 5, pp. 388-393.
Sasoh M, Smiddy WE. Diode laser endophotocoagulation. Retina. 1995 Nov 13;15(5):388-393.
Sasoh, M. ; Smiddy, William E. / Diode laser endophotocoagulation. In: Retina. 1995 ; Vol. 15, No. 5. pp. 388-393.
@article{6ae62ed9a01e4a57a94e5d79fa6e3bc6,
title = "Diode laser endophotocoagulation",
abstract = "Purpose: To evaluate the utility, safety, and reliability of diode laser endophotocoagulation in a sizable clinical series. Methods: Two hundred twenty-six consecutive eyes treated with diode endophotocoagulation were studied prospectively. Surgical indications included proliferative diabetic retinopathy (134 eyes), proliferative vitreoretinopathy (27 eyes), complicated retinal detachment (50 eyes), and miscellaneous (15 eyes). A retrospective comparison group of 67 consecutive eyes undergoing vitrectomy with argon endolaser photocoagulation was also studied. Results: The desired intraoperative effect of diode endophotocoagulation was achieved in 99.6{\%} cases without complication. Final visual acuity was improved in 159 eyes (71{\%}), and was 5/200 or better in 157 eyes (70{\%}) with diode endophotocoagulation. In comparison, final visual acuity was improved in 48 eyes (73{\%}), and was 5/200 or better in 45 eyes (68{\%}) for argon endophotocoagulation. No statistically significant difference was found between the two groups regarding rate of visual improvement or final visual results. Conclusion: This series supports the conclusion that the diode laser is as safe, reliable, and effective for endophotocoagulation as argon treatment.",
keywords = "diode laser, endophotocoagulation, vitrectomy",
author = "M. Sasoh and Smiddy, {William E}",
year = "1995",
month = "11",
day = "13",
language = "English",
volume = "15",
pages = "388--393",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Diode laser endophotocoagulation

AU - Sasoh, M.

AU - Smiddy, William E

PY - 1995/11/13

Y1 - 1995/11/13

N2 - Purpose: To evaluate the utility, safety, and reliability of diode laser endophotocoagulation in a sizable clinical series. Methods: Two hundred twenty-six consecutive eyes treated with diode endophotocoagulation were studied prospectively. Surgical indications included proliferative diabetic retinopathy (134 eyes), proliferative vitreoretinopathy (27 eyes), complicated retinal detachment (50 eyes), and miscellaneous (15 eyes). A retrospective comparison group of 67 consecutive eyes undergoing vitrectomy with argon endolaser photocoagulation was also studied. Results: The desired intraoperative effect of diode endophotocoagulation was achieved in 99.6% cases without complication. Final visual acuity was improved in 159 eyes (71%), and was 5/200 or better in 157 eyes (70%) with diode endophotocoagulation. In comparison, final visual acuity was improved in 48 eyes (73%), and was 5/200 or better in 45 eyes (68%) for argon endophotocoagulation. No statistically significant difference was found between the two groups regarding rate of visual improvement or final visual results. Conclusion: This series supports the conclusion that the diode laser is as safe, reliable, and effective for endophotocoagulation as argon treatment.

AB - Purpose: To evaluate the utility, safety, and reliability of diode laser endophotocoagulation in a sizable clinical series. Methods: Two hundred twenty-six consecutive eyes treated with diode endophotocoagulation were studied prospectively. Surgical indications included proliferative diabetic retinopathy (134 eyes), proliferative vitreoretinopathy (27 eyes), complicated retinal detachment (50 eyes), and miscellaneous (15 eyes). A retrospective comparison group of 67 consecutive eyes undergoing vitrectomy with argon endolaser photocoagulation was also studied. Results: The desired intraoperative effect of diode endophotocoagulation was achieved in 99.6% cases without complication. Final visual acuity was improved in 159 eyes (71%), and was 5/200 or better in 157 eyes (70%) with diode endophotocoagulation. In comparison, final visual acuity was improved in 48 eyes (73%), and was 5/200 or better in 45 eyes (68%) for argon endophotocoagulation. No statistically significant difference was found between the two groups regarding rate of visual improvement or final visual results. Conclusion: This series supports the conclusion that the diode laser is as safe, reliable, and effective for endophotocoagulation as argon treatment.

KW - diode laser

KW - endophotocoagulation

KW - vitrectomy

UR - http://www.scopus.com/inward/record.url?scp=0028881868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028881868&partnerID=8YFLogxK

M3 - Article

C2 - 8594630

AN - SCOPUS:0028881868

VL - 15

SP - 388

EP - 393

JO - Retina

JF - Retina

SN - 0275-004X

IS - 5

ER -